Cargando…

Size, Shape, and Phase of Nanoscale Uric Acid Particles

[Image: see text] Uric acid particles are formed due to hyperuricemia, and previous works have focused on understanding the surface forces, crystallization, and growth of micron- and supermicron-sized particles. However, little to no work has furthered our understanding about uric acid nanonuclei th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastogi, Dewansh, Asa-Awuku, Akua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301715/
https://www.ncbi.nlm.nih.gov/pubmed/35874264
http://dx.doi.org/10.1021/acsomega.2c01213
_version_ 1784751478299164672
author Rastogi, Dewansh
Asa-Awuku, Akua
author_facet Rastogi, Dewansh
Asa-Awuku, Akua
author_sort Rastogi, Dewansh
collection PubMed
description [Image: see text] Uric acid particles are formed due to hyperuricemia, and previous works have focused on understanding the surface forces, crystallization, and growth of micron- and supermicron-sized particles. However, little to no work has furthered our understanding about uric acid nanonuclei that precipitate during the initial stages of kidney stone formation. In this work, we generate nanosized uric acid particles by evaporating saturated solution droplets of uric acid. Furthermore, we quantify the effects of drying rate on the morphology of uric acid nanonuclei. An aerosol droplet drying method generates uric acid nanoparticles in the size range of 20–200 nm from aqueous droplets (1–6 μm). Results show that uric acid nanonuclei are non-spherical with a shape factor value in the range of 1.1–1.4. The shape factor values change with drying rate and indicate that the nanoparticle morphology is greatly affected by drying kinetics. The nanonuclei are amorphous but can grow to form crystalline micron-sized particles. Indeed, a pre-crystallization phase was observed for heterogeneous nucleation of uric acid particles in the size range of a few hundred nanometers. Our findings show that the morphology of uric acid nanonuclei is significantly different from that of crystalline supermicron-sized particles. These new findings imply that the dissolution characteristics, surface properties, elimination, and medical treatment of uric acid nanonuclei formed during the initial stages of nucleation must be reconsidered.
format Online
Article
Text
id pubmed-9301715
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93017152022-07-22 Size, Shape, and Phase of Nanoscale Uric Acid Particles Rastogi, Dewansh Asa-Awuku, Akua ACS Omega [Image: see text] Uric acid particles are formed due to hyperuricemia, and previous works have focused on understanding the surface forces, crystallization, and growth of micron- and supermicron-sized particles. However, little to no work has furthered our understanding about uric acid nanonuclei that precipitate during the initial stages of kidney stone formation. In this work, we generate nanosized uric acid particles by evaporating saturated solution droplets of uric acid. Furthermore, we quantify the effects of drying rate on the morphology of uric acid nanonuclei. An aerosol droplet drying method generates uric acid nanoparticles in the size range of 20–200 nm from aqueous droplets (1–6 μm). Results show that uric acid nanonuclei are non-spherical with a shape factor value in the range of 1.1–1.4. The shape factor values change with drying rate and indicate that the nanoparticle morphology is greatly affected by drying kinetics. The nanonuclei are amorphous but can grow to form crystalline micron-sized particles. Indeed, a pre-crystallization phase was observed for heterogeneous nucleation of uric acid particles in the size range of a few hundred nanometers. Our findings show that the morphology of uric acid nanonuclei is significantly different from that of crystalline supermicron-sized particles. These new findings imply that the dissolution characteristics, surface properties, elimination, and medical treatment of uric acid nanonuclei formed during the initial stages of nucleation must be reconsidered. American Chemical Society 2022-07-05 /pmc/articles/PMC9301715/ /pubmed/35874264 http://dx.doi.org/10.1021/acsomega.2c01213 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Rastogi, Dewansh
Asa-Awuku, Akua
Size, Shape, and Phase of Nanoscale Uric Acid Particles
title Size, Shape, and Phase of Nanoscale Uric Acid Particles
title_full Size, Shape, and Phase of Nanoscale Uric Acid Particles
title_fullStr Size, Shape, and Phase of Nanoscale Uric Acid Particles
title_full_unstemmed Size, Shape, and Phase of Nanoscale Uric Acid Particles
title_short Size, Shape, and Phase of Nanoscale Uric Acid Particles
title_sort size, shape, and phase of nanoscale uric acid particles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301715/
https://www.ncbi.nlm.nih.gov/pubmed/35874264
http://dx.doi.org/10.1021/acsomega.2c01213
work_keys_str_mv AT rastogidewansh sizeshapeandphaseofnanoscaleuricacidparticles
AT asaawukuakua sizeshapeandphaseofnanoscaleuricacidparticles